Butalbital, Acetaminophen, Caffeine

Product NDC
53002-6031
11-digit product format
530026031
Labeler code
53002
Product ID
53002-6031_2f87defd-d0a8-4137-a063-70d1d6b7456a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Butalbital, Acetaminophen, and Caffeine
Dosage form
TABLET, COATED
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA209587
Marketing category
ANDA
Marketing start
2019-03-05
Marketing end
0000-00-00
Substance
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Active strength
325 mg/1; mg/1; mg/1
Pharmacologic classes
Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
DEA schedule
CIII
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
53002-6031-15300260310110 TABLET, COATED in 1 BOTTLE (53002-6031-1) 2022-04-010000-00-00NoNoCurrent
53002-6031-25300260310220 TABLET, COATED in 1 BOTTLE (53002-6031-2) 2022-04-010000-00-00NoNoCurrent
53002-6031-35300260310330 TABLET, COATED in 1 BOTTLE (53002-6031-3) 2022-04-010000-00-00NoNoCurrent